<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The aim of this study was to assess the incidence and clinical predictors of the development of new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) over medium-term follow-up, in patients treated with permanent pacing in daily clinical practice.METHODS AND RESULTS: We retrospectively enrolled <z:hpo ids='HP_0000001'>all</z:hpo> consecutive patients who underwent single- or dual-chamber pacemaker implantation at the study centre </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with a left ventricular ejection fraction (LVEF) ≤35% or a prior diagnosis of HF were excluded </plain></SENT>
<SENT sid="2" pm="."><plain>Ventricular leads were routinely implanted in the right apex </plain></SENT>
<SENT sid="3" pm="."><plain>Pacemakers were implanted in 490 patients with a standard pacemaker indication and LVEF &gt;35% </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011713'>Left bundle-branch block</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>) was reported in 30 (8%) patients, and an LVEF &lt;50% in 64 (13%) patients </plain></SENT>
<SENT sid="5" pm="."><plain>During a follow-up of 27 ± 21 months, 32 (7%) patients reached the combined endpoint of HF <z:hpo ids='HP_0011420'>death</z:hpo> or hospitalization </plain></SENT>
<SENT sid="6" pm="."><plain>On multivariate analysis, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> (HR, 3.50; 95% CI, 1.1-11.1; P = 0.033) and LVEF &lt;50% (HR, 5.1; 95% CI, 1.9-14.2; P = 0.002) were confirmed as independent predictors of HF <z:hpo ids='HP_0011420'>death</z:hpo> or hospitalization </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with LVEF &lt;50% and/or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> displayed significantly higher rates of HF <z:hpo ids='HP_0011420'>death</z:hpo> or hospitalization (log-rank test, <z:hpo ids='HP_0000001'>all</z:hpo> P&lt;0.001).CONCLUSION: The majority of patients with a standard indication for permanent pacing and <z:mpath ids='MPATH_458'>normal</z:mpath> LV function remained in a clinically stable condition after pacemaker implantation </plain></SENT>
<SENT sid="8" pm="."><plain>However, ∼7% of patients developed new-<z:hpo ids='HP_0003674'>onset</z:hpo> HF over a period of follow-up of 27 months, and the presence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> and LVEF &lt;50% at the baseline predicted HF <z:hpo ids='HP_0011420'>death</z:hpo> or hospitalization </plain></SENT>
</text></document>